Potency of Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) Used in Combination with Other Human Immunodeficiency Virus NNRTIs, NRTIs, or Protease Inhibitors

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Full description

Saved in:
Bibliographic Details
Published inAntimicrobial Agents and Chemotherapy Vol. 46; no. 6; pp. 1640 - 1646
Main Authors KING, Robert W, KLABE, Ronald M, REID, Carol D, ERICKSON-VIITANEN, Susan K
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.06.2002
Subjects
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral Agents
Benzoxazines
Biological and medical sciences
Cells, Cultured
Drug Combinations
Drug Interactions
HIV Protease Inhibitors
HIV Protease Inhibitors - pharmacology
HIV Reverse Transcriptase - biosynthesis
HIV-1
HIV-1 - drug effects
HIV-1 - enzymology
Humans
Medical sciences
Nevirapine - pharmacology
Nucleosides - pharmacology
Oxazines - pharmacology
Pharmacology. Drug treatments
Reverse Transcriptase Inhibitors
Reverse Transcriptase Inhibitors - pharmacology
Virus Replication - drug effects
Drug combination
RNA-directed DNA polymerase
HIV-1 virus
Enzyme
Transferases
Non nucleoside compound
Quinazoline derivatives
Retroviridae
Enzyme inhibitor
Lentivirus
Efavirenz
In vitro
Synergism
Biological activity
Virus
Peptidases
Nucleotidyltransferases
Hydrolases
Antiviral
Replication
Drug interaction
Human immunodeficiency virus
Online AccessGet full text

Cover

More Information
Summary:Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Corresponding author. Mailing address: The Experimental Station, Bristol-Myers Squibb Pharma, P.O. Box 80336, Bldg. E336, Rm 205A, Wilmington, DE 19880-0336. Phone: (302) 695-9354. Fax: (302) 695-9420. E-mail: robert.king@bms.com.
ISSN:0066-4804
1098-6596
DOI:10.1128/AAC.46.6.1640-1646.2002